Skip to main content
SpringerLink
Log in

Clinical, endocrine, and molecular findings in 17β -hydroxysteroid dehydrogenase type 3 deficiency

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The 17β-hydroxysteroid dehydrogenases (17βHSD) gene family comprises different enzymes involved in the biosynthesis of active steroid hormones. The 17βHSD type 3 (17βHSD3) isoenzyme catalyzes the reductive conversion of the inactive C19-steroid, Δ4-androstenedione (Δ4- A), into the biologically active androgen, testosterone (T), in the Leydig cells of the testis. It is encoded by the 17β-hydroxysteroid dehydrogenase type 3 (HSD17B3) gene, which maps to chromosome 9q22. Mutations in the HSD17B3 gene are associated with a rare form of 46,XY disorder of sex development referred to as 17βHSD3 deficiency (or as 17-ketosteroid reductase deficiency), due to impaired testicular conversion of Δ4-A into T. 46,XY patients with 17βHSD3 deficiency are usually classified as female at birth, raised as such, but develop secondary male features at puberty. Diagnosis, and consequently early treatment, is difficult because clinical signs from birth until puberty may be mild or absent. Biochemical diagnosis of 17βHSD3 deficiency requires measurement of serum T/Δ4-A ratio after hCG stimulation test in pre-pubertal subjects, while baseline values seem to be informative in early infancy and adolescence. However, low basal T/Δ4-A ratio is not specific for 17βHSD3 deficiency, being sometimes also found in patients with other defects in T synthesis or with Leydig cells hypoplasia. Mutational analysis of the 17HSDB3 gene is useful in confirming the clinical diagnosis of 17βHSD3 deficiency. This review describes clinical findings, diagnosis, and molecular basis of this rare disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baulieu EE. Neurosteroids: a new function in the brain. Biol Cell 1991, 71: 3–10.

    Article  PubMed  CAS  Google Scholar 

  2. Labrie F. Intracrinology. Mol Cell Endocrinol 1991, 78: C113–8.

    Article  PubMed  CAS  Google Scholar 

  3. Labrie F, Luu-The V, Lin SX, et al. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000, 25: 1–16.

    Article  PubMed  CAS  Google Scholar 

  4. Labrie F, Bélanger A, Luu-The V, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 1998, 63: 322–8.

    Article  PubMed  CAS  Google Scholar 

  5. Stewart PM, Sheppard MC. Novel aspects of hormone action: intracellular ligand supply and its control by a series of tissue specific enzymes. Mol Cell Endocrinol 1992, 83: C13–8.

    Article  PubMed  CAS  Google Scholar 

  6. Lee PA, Houk CP, Ahmed SF, Hughes IA. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006, 118: 488–500.

    Google Scholar 

  7. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004, 25: 947–70.

    Article  PubMed  CAS  Google Scholar 

  8. Hoppe U, Holterhus PM, Wünsch L, et al. Tissue-specific transcription profiles of sex steroid byosinthesis enzymes and the androgen receptor. J Mol Med 2006, 84: 651–9.

    Article  PubMed  CAS  Google Scholar 

  9. Khan N, Sharma KK, Andersson S, Auchus RJ. Human 17beta-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells. Arch Biochem Biophys 2004, 429: 50–9.

    Article  PubMed  CAS  Google Scholar 

  10. Andersson S. Molecular genetics of androgenic 17 beta-hydroxysteroid dehydrogenases. J Steroid Biochem Mol Biol 1995, 55: 533–4.

    Article  PubMed  CAS  Google Scholar 

  11. Geissler WM, Davis DL, Wu L, et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet 1994, 7: 34–9.

    Article  PubMed  CAS  Google Scholar 

  12. Xiaofei D, Rosenfeld RL, Quin K. Molecular mechanisms regulating basal espression of the human 17β-hydroxy steroid dehydrogenase type 3 (HSD17B3) gene promoter in Leydig cells. In: Endocrine 2006, Boston, P1-372.

  13. Andersson S, Geissler WM, Wu L, et al. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996, 81: 130–6.

    PubMed  CAS  Google Scholar 

  14. Griffin JE, Wilson EM. Disorders of sexual differentiation. In: Walsh PC, Resnik AB, Stamey TA, Vaughan ED Jr, eds. Campbell’s textbook of urology Philadelphia: WB Saunders, 1992: 1509–42.

    Google Scholar 

  15. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995, 16: 271–321.

    PubMed  CAS  Google Scholar 

  16. Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993, 14: 577–93.

    PubMed  CAS  Google Scholar 

  17. Gobinet J, Poujol N, Sultan Ch. Molecular action of androgens. Mol Cell Endocrinol 2002, 198: 15–24.

    Article  PubMed  CAS  Google Scholar 

  18. Miller WL, Huang N, Pandey AV, Flück CE, Agrawal V. P450 oxidoreductase deficiency: a new disorder of steroidogenesis. Ann N Y Acad Sci 2005, 1061: 100–8.

    Article  PubMed  CAS  Google Scholar 

  19. Noguchi K, Saito K. [Disorder of androgen biosynthesis]. Nippon Rinsho 2004, 62: 339–43.

    PubMed  Google Scholar 

  20. Saez JM, De Peretti E, Morera AM, David M, Bertrand J. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J Clin Endocrinol Metab 1971, 32(5): 604–10.

    Article  PubMed  CAS  Google Scholar 

  21. Grumbach MM, Shaw EB. Further studies on the treatment of congenital adrenal hyperplasia with cortisone: IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism, by John F. Crigler Jr, MD, Samuel H. Silverman, MD, and Lawson Wilkins, MD, Pediatrics, 1952, 10: 397–413. Pediatrics 1998, 102: 215–21.

    Google Scholar 

  22. Can S, Zhu YS, Cai LQ, et al. The identification of 5 alphareductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. J Clin Endocrinol Metab 1998, 83: 560–9.

    PubMed  CAS  Google Scholar 

  23. Eckstein B, Cohen S, Farkas A, Rösler A. The nature of the defect in familial male pseudohermaphroditism in Arabs of Gaza. J Clin Endocrinol Metab 1989, 68: 477–85.

    Article  PubMed  CAS  Google Scholar 

  24. Ulloa-Aguirre A, Bassol S, Poo J, et al. Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency. J Clin Endocrinol Metab 1985, 60: 639–43.

    Article  PubMed  CAS  Google Scholar 

  25. Balducci R, Toscano V, Wright F, et al. Familial male pseudohermaphroditism with gynaecomastia due to 17 beta-hydroxysteroid dehydrogenase deficiency. A report of 3 cases. Clin Endocrinol (Oxf) 1985, 23: 439–44.

    Article  CAS  Google Scholar 

  26. Mendonca BB, Inacio M, Arnhold IJ, et al. Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 2000, 79: 299–309.

    Article  CAS  Google Scholar 

  27. Rogers DG, Chasalow FI, Blethen SL. Partial deficiency in 17-ketosteroid reductase presenting as gynecomastia. Steroids 1985, 45: 195–200.

    Article  PubMed  CAS  Google Scholar 

  28. Castro-Magana M, Angulo M, Uy J. Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. N Engl J Med 1993, 328: 1297–301.

    Article  PubMed  CAS  Google Scholar 

  29. Pang SY, Softness B, Sweeney WJ 3rd, New MI. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. N Engl J Med 1987, 316: 1295–301.

    Article  PubMed  CAS  Google Scholar 

  30. Rösler A, Silverstein S, Abeliovich D. A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996, 81: 1827–31.

    PubMed  Google Scholar 

  31. Mendonca BB, Arnhold IJ, Bloise W, Andersson S, Russell DW, Wilson JD. 17Beta-hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab 1999, 84: 802–4.

    PubMed  CAS  Google Scholar 

  32. Saez JM, Morera AM, De Peretti E, Bertrand J. Further in vivo studies in male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect (compared to a case of testicular feminization). J Clin Endocrinol Metab 1972, 34: 598–600.

    Article  PubMed  CAS  Google Scholar 

  33. Imperato-McGinley J, Peterson RE, Stoller R, Goodwin WE. Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab 1979, 49: 391–5.

    Article  PubMed  CAS  Google Scholar 

  34. Goebelsmann U, Horton R, Mestman JH, et al. Male pseudohermaphroditism due to testicular 17β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1973, 36: 867–79.

    Article  PubMed  CAS  Google Scholar 

  35. Martel C, Rhéaume E, Takahashi M, et al. Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol 1992, 41: 597–603.

    Article  PubMed  CAS  Google Scholar 

  36. Luu The V, Lachance Y, Labrie C, et al. Full length cDNA structure and deduced amino acid sequence of human 3 beta-hydroxy-5-ene steroid dehydrogenase. Mol Endocrinol 1989, 3: 1310–2.

    Article  PubMed  CAS  Google Scholar 

  37. Rosler A. 17β-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population. Pediatric Endocrinology Reviews 2006, 3 (suppl 3): 455–61.

    PubMed  Google Scholar 

  38. Van Poucke C, Van de Velde M, Van Peteghem C. Combination of liquid cromatography/tandem mass spectrometry and gas cromatography/mass spectrometry for the detection of 21 anabolic steroid residues in bovine urine. J Mass Spectrom 2005, 40: 731–8.

    Article  PubMed  CAS  Google Scholar 

  39. Rösler A, Bélanger A, Labrie F. Mechanisms of androgen production in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1992, 75: 773–8.

    PubMed  Google Scholar 

  40. Bilbao JR, Loridan L, Audí L, Gonzalo E, Castano L. A novel missense (R80W) mutation in 17-beta-hydroxysteroid dehydrogenase type 3 gene associated with male pseudohermaphroditism. Eur J Endocrinol 1998, 139: 330–3.

    Article  PubMed  CAS  Google Scholar 

  41. Lindqvist A, Hughes IA, Andersson S. Substitution mutation C268Y causes 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 2001, 86: 921–3.

    PubMed  CAS  Google Scholar 

  42. Moghrabi N, Hughes IA, Dunaif A, Andersson S. Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3). J Clin Endocrinol Metab 1998, 83: 2855–60.

    PubMed  CAS  Google Scholar 

  43. Boehmer AL, Brinkmann AO, Sandkuijl LA, et al. 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999, 84: 4713–21.

    PubMed  CAS  Google Scholar 

  44. Twesten W, Holterhus P, Sippell WG, et al. Clinical, endocrine, and molecular genetic findings in patients with 17beta-hydroxysteroid dehydrogenase deficiency. Horm Res 2000, 53: 26–31.

    Article  PubMed  CAS  Google Scholar 

  45. Bachelot A, Chakhtoura Z, Kuttenn F, Morel Y, Touraine PH. 17 beta hydroxysteroid dehydrogenase deficiency cause by homozygous h271r mutation. In: Endocrine 2006, Boston. p. P 156.

  46. Faienza MF, Giordani L, Acquafredda A, et al. 46,XY caused by a rare mutation of the 17-β-hydroxysteroid dehydrogenase deficiency type 3 gene. IJP 2007, 33: 13–6.

    Google Scholar 

  47. Margiotti K, Kim E, Pearce CL, Spera E, Novelli G, Reichardt JK. Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men. Prostate 2002, 53: 65–8.

    Article  PubMed  CAS  Google Scholar 

  48. Hiort O, Reinecke S, Thyen U, et al. Puberty in disorders of somatosexual differentiation. J Pediatr Endocrinol Metab 2003, 16 (Suppl 2): 297–306.

    PubMed  CAS  Google Scholar 

  49. Saggese G, Bertelloni S, Navari S, Bertacca L, Geraci S. [Neonate with ambiguous genitalia: medical therapy after the first weeks of life]. Minerva Pediatr 2003, 55(Suppl 1): 58–62.

    PubMed  CAS  Google Scholar 

  50. Farkas A, Rosler A. Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency. Eur J Pediatr 1993, 152(Suppl 2): S88–90.

    Article  PubMed  Google Scholar 

  51. Wilson JD. The role of androgens in male gender role behavior. Endocr Rev 1999, 20: 726–37.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedicine of Development Age, University of Bari, Bari, Italy

    M. F. Faienza, L. Giordani, M. Delvecchio & L. Cavallo MD

Authors
  1. M. F. Faienza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Giordani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Delvecchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Cavallo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Cavallo MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faienza, M.F., Giordani, L., Delvecchio, M. et al. Clinical, endocrine, and molecular findings in 17β -hydroxysteroid dehydrogenase type 3 deficiency. J Endocrinol Invest 31, 85–91 (2008). https://doi.org/10.1007/BF03345572

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345572

En]Keywords

Search

Navigation